Back to Invesco Ltd. Invesco Ltd.

NBIXNBIX
Showing 8 of 23 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in NEUROCRINE BIOSCIENCES INC

Invesco Ltd. holds 1.1M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $181.6M as of 2026-Q2. The position was increased (+202.6% shares). NBIX represents 0.0% of Invesco Ltd.'s portfolio.

Current Value

$181.6M

Current Shares

1.1M

Total Value Change

+$80.8M

Total Shares Change

+202,652

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+202.6%
$181.6M0.0%$168.54
49
2026-Q1
Increased
356,009
+3.7%
$46.9M0.0%$131.14
30
2025-Q4
Increased
343,421
+6.1%
$48.7M0.0%$140.95
31
2025-Q3
Increased
323,611
+11.9%
$45.4M0.0%$140.27
33
2025-Q2
Decreased
289,245
-49.0%
$36.4M0.0%$125.42
0
2025-Q1
Decreased
567,320
-40.3%
$62.7M0.0%$113.16
0
2024-Q4
Increased
949,512
+8.6%
$129.6M0.0%$137.06
33
2024-Q3
Decreased
874,665
-30.5%
$100.8M0.0%$115.06
0

Other major holders of NBIX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used